NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases plans to grant up to $10.3 million in fiscal 2010 to fund research partnerships focused on developing diagnostics and therapeutics for drug-resistant bacteria and eukaryotic parasites.

NIAID will fund a range of research approaches for NIAID Category A, B, or C bacteria or eukaryotic parasites, as well as development of diagnostics or therapeutics against non-listed organisms for which naturally-occurring drug resistance is a growing clinical problem.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.